Therapy Areas: Central Nervous System
19 September 2023 - Caliway Biopharmaceuticals, a Taiwan-based biopharmaceutical company, announced on Monday that it has completed enrolment of subjects in the CBL-0201EFP Phase 2-stage 2 study.The s...
18 September 2023 - UK pharmaceutical company Pharmanovia announced on Monday the expansion of its neurology portfolio through the acquisition of 11 central nervous system (CNS) brands from French hea...
11 September 2023 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) announced on Monday that its Tagrisso (osimertinib), when combined with chemotherapy, has demonstrated a ...
8 September 2023 - Clinical-stage pharmaceutical company Plus Therapeutics Inc (Nasdaq:PSTV) announced on Friday an expansion of its supply agreement with Biocept, securing an option for exclusive lic...
28 August 2023 - Specialised Therapeutics Asia Pte Ltd (ST), an independent biopharmaceutical company, announced on Sunday that it is collaborating with Treeway BV, a Netherlands based biotechnology c...
11 August 2023 - Apex Labs Ltd., a Canada-based pharmaceutical company involved in mental health care with psilocybin treatments, announced on Thursday that it has named Dr Mark Johnston, MD, FRCPC, a...